FDA and CMS Announce New Steps to Advance Gene Therapies and Expand Access for Patients with Rare Diseases - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA and CMS Outline Initiatives to Support Gene Therapy Development and Improve Access for People with Rare Diseases

  • By

  • Assistant Secretary for Public Affairs (ASPA)

  • October 27, 2026

Share

Original Source(s)

Related Content